Metabolisches Syndrom

  • H. Hauner
  • F. A. Gries
Chapter

Zusammenfassung

Der Begriff des metabolischen Syndroms beschreibt das gemeinsame Vorkommen von abdomineller Adipositas, Glukoseintoleranz bzw.Typ-2-Diabetes mellitus, Dyslipoproteinämie und Hypertonie. Eine erweiterte Definition schließt eine gestörte Fibrinolyse, eine Mikroalbuminurie und eine Hyperurikämie ein (Übersicht 8.1). Langzeitstudien zeigen, dass die Verknüpfung dieser Komponenten mit einem hohen kardiovaskulären Risiko verbunden ist. (Hanefeld et al. 1996, Schulte et al. 1999).

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alessi MC, Pirelli F, Morange P et al (1997) Production of plasminogen activator inhibitor-1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease. Diabetes 46:860–867PubMedCrossRefGoogle Scholar
  2. Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMedCrossRefGoogle Scholar
  3. Chan JM, Rimm EB, Colditz GA et al (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961–969PubMedCrossRefGoogle Scholar
  4. Chiasson JL, Josse RG, Gomis R et al, STOP-NIDDM Trial Research Group (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM-randomised trial. Lancet 359:2072–2077PubMedCrossRefGoogle Scholar
  5. Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481–486PubMedCrossRefGoogle Scholar
  6. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCentralCrossRefGoogle Scholar
  7. Dietze D, Koenen M, Röhrig K et al (2002) Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51:2369–2376PubMedCrossRefGoogle Scholar
  8. Engeli S, Sharma AM (2000) Role of adipose tissue for cardiovascular-renal regulation in health and disease. Horm Metab Res 32:485–499PubMedCrossRefGoogle Scholar
  9. Everson SA, Goldberg DE, Helmrich SP et al (1998) Weight gain and risk of developing insulin resistance syndrome. Diabetes Care 21:1637–1643PubMedCrossRefGoogle Scholar
  10. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRefGoogle Scholar
  11. Gottschling-Zeller H, Birgel M, Röhrig K, Hauner H (2000) Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture. Metabolism 49:666–671PubMedCrossRefGoogle Scholar
  12. Hanefeld M, Fischer S, Julius U et al (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577–1583PubMedCrossRefGoogle Scholar
  13. Hauner H (1995) Ernährung und metabolisches Syndrom. Internist 36:1040–1045PubMedGoogle Scholar
  14. Hitzenberger K, Richter-Quittner M (1921) Ein Beitrag zum Stoffwechsel bei der vaskulären Hypertonie. Wiener Archiv für Innere Medizin 2:189–216Google Scholar
  15. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor alpha: direct role in obesity-linked insulin resistance. Science 259:87–91PubMedCrossRefGoogle Scholar
  16. Hu FB, Manson JE, Stampfer MJ et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797PubMedCrossRefGoogle Scholar
  17. Hube F, Hauner H (1999) The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Horm Metab Res 31:626–631PubMedCrossRefGoogle Scholar
  18. Jahnke K, Daweke H, Liebermeister H et al (1969) Hormonal and metabolic aspects of obesity in humans. Proceedings of the 6th Congress of the International Diabetes Federation, J Östman (ed.). Excerpta Medica Foundation, Amsterdam, S 533–539Google Scholar
  19. Lee CD, Jackson AS, Blair SN (1998) US weight guidelines: is it also important to consider cardiorespiratory fitness? Int J Obes Relat Metab Dis 22(Suppl.2):S2–S7Google Scholar
  20. Liese AD, Mayer-Davis EJ, Haffner SM (1998): Development of the multiple metabolic syndrome: an epidemiological perspective. Epidemiol Rev 20:157–172PubMedCrossRefGoogle Scholar
  21. Manson JE, Willett WC, Stampfer MJ et al (1995) Body weight and mortality among women. N Engl J Med 333:677–685PubMedCrossRefGoogle Scholar
  22. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S (1998) The metabolically obese, normal-weight individual revisited. Diabetes 47:699–713PubMedCrossRefGoogle Scholar
  23. Schling P, Mallow H, Trindl A, Löffler G (1999) Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 23:336–341PubMedCrossRefGoogle Scholar
  24. Schulte H, Cullen P, Assmann G (1999) Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM). Atherosclerosis 144:199–209PubMedCrossRefGoogle Scholar
  25. SIGN (1996) Scottish Intercollegiate Guidelines Network: Obesity in Scotland. Integrating prevention with weight managementGoogle Scholar
  26. Sinaiko AR, Donahne RP, Jacobs DR, Prineas RJ (1999) Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin and lipids in young adults. The Minneapolis Children’s Blood Pressure. Circulation 99:1471–1476Google Scholar
  27. Skurk T, Lee YM, Hauner H (2001) Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension 37:1336–1340PubMedCrossRefGoogle Scholar
  28. Stevens J, Tyroler HA, Cai J et al (1998) Body weight change and carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 147:563–573PubMedCrossRefGoogle Scholar
  29. Tuomilehto J, Lindström J, Eriksson JG et al, Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRefGoogle Scholar
  30. Waldhäusl W, Roden M (2000) Effects of free fatty acids on glucose transport/phosphorylation in skeletal muscle in humans. Current opinion in Endocrinology 7:211–216CrossRefGoogle Scholar
  31. Wing RR, Koeske R, Epstein LH et al (1987) Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 147:1749–1753PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • H. Hauner
  • F. A. Gries

There are no affiliations available

Personalised recommendations